Preventing human papillomavirus–related cancers: we are all in this together

Academic Article


  • Human papillomavirus–related cancers, which include cervical, vulvovaginal, anal, and oropharyngeal cancers, are on the rise in the United States. Although the human papillomavirus vaccine has been on the market for 10 years, human papillomavirus vaccination rates are well below national goals. Research identified many barriers and facilitators to human papillomavirus vaccination, and provider recommendation remains the most important factor in parental and patient decisions to vaccinate. While much of the burden of human papillomavirus vaccine provision falls on pediatricians and primary care providers, they cannot do it alone. As clinicians who care for a large proportion of human papillomavirus–related conditions, obstetrician-gynecologists and other women's health care providers must share the responsibility for vaccination of eligible patients. Obstetrician-gynecologists can support the efforts to eradicate human papillomavirus–related disease in their patients and their families via multiple avenues, including providing the human papillomavirus vaccine and being community leaders in support of vaccination.
  • Digital Object Identifier (doi)

    Author List

  • Dilley S; Scarinci I; Kimberlin D; Straughn JM
  • Start Page

  • 576.e1
  • End Page

  • 576.e5
  • Volume

  • 216
  • Issue

  • 6